Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000227 · ClinicalTrials.gov registry record · Phase 2
Alternate-Day Buprenorphine Administration. Phase VIII - 9
A Phase 2 study, sponsored by University of Vermont.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000227 is a Phase 2 study that has completed, run by University of Vermont.
The verdict
NCT00000227, a Phase 2 study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to evaluate open buprenorphine dosing with dose choice.
Interventions
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1994-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000227
The ClinicalTrials.gov registry entry for NCT00000227 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine is the first listed.
NCT00000227 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000227 about?
NCT00000227 is a clinical study titled "Alternate-Day Buprenorphine Administration. Phase VIII - 9". The purpose of this study is to evaluate open buprenorphine dosing with dose choice.
What is the current status of trial NCT00000227?
This trial is currently completed. It is a Phase 2 study. The study started on 1994-08.
What interventions are being tested in trial NCT00000227?
The interventions under investigation include: Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT00000227?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.